» Articles » PMID: 16844725

Efficacy of Speech Pathology Management for Chronic Cough: a Randomised Placebo Controlled Trial of Treatment Efficacy

Overview
Journal Thorax
Date 2006 Jul 18
PMID 16844725
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic cough that persists despite medical treatment may respond to speech pathology intervention, but the efficacy of such treatment has not been investigated in prospective randomised trials. The aim of this study was to determine the efficacy of a speech pathology intervention programme for chronic cough.

Methods: A single blind, randomised, placebo controlled trial was conducted in 87 patients with chronic cough that persisted despite medical treatment. Patients were randomly allocated to receive either a specifically designed speech pathology intervention or a placebo intervention. Participants in both groups attended four intervention sessions with a qualified speech pathologist.

Results: Participants in the treatment group had a significant reduction in cough (8.9 to 4.6, p<0.001), breathing (7.9 to 4.7, p<0.001), voice (7.3 to 4.6, p<0.001) upper airway (8.9 to 5.9, p<0.001) symptom scores and limitation (2.3 to 1.6, p<0.001) ratings following intervention. There was also a significant reduction in breathing (6.8 to 5.6, p = 0.047), cough (7.6 to 6.3, p = 0.014), and limitation (2.3 to 2.0, p = 0.038) scores in the placebo group, but the degree of improvement was significantly less than in the treatment group (p<0.01). Clinical judgement of outcome indicated successful ratings in 88% of participants in the treatment group compared with 14% in the placebo group (p<0.001).

Conclusion: Speech pathology is an effective management intervention for chronic cough which may be a viable alternative for patients who do not respond to medical treatment.

Citing Articles

Reframing Refractory Chronic Cough: The Role of Interoception.

Slovarp L, Reynolds J, Gillespie A, Jette M Lung. 2025; 203(1):32.

PMID: 39937307 PMC: 11821735. DOI: 10.1007/s00408-025-00786-7.


Cough-hypersensitivity Syndrome-A New Paradigm in the Evaluation of Chronic Refractory Cough and Its Novel Therapeutic Horizons-A Review.

Khan D, Chaudhry H, Iqbal P, Shehzad D, Yasir M, Khan W J Community Hosp Intern Med Perspect. 2025; 14(6):75-81.

PMID: 39839174 PMC: 11745195. DOI: 10.55729/2000-9666.1417.


Examining Cough's Role and Relief Strategies in Interstitial Lung Disease.

Lim C, Khan S, Alsibai T, Sathiyamoorthy G J Clin Med. 2025; 14(1.

PMID: 39797373 PMC: 11721155. DOI: 10.3390/jcm14010291.


Efficacy of behavioral cough suppression therapy for refractory chronic cough or unexplained chronic cough: a meta-analysis of randomized controlled trials.

Yi B, Wang S, Xu X, Yu L Ther Adv Respir Dis. 2024; 18:17534666241305952.

PMID: 39707881 PMC: 11663276. DOI: 10.1177/17534666241305952.


Abnormal breathing pattern features in chronic refractory cough.

Jeffery J, Vertigan A, Bone S, Gibson P ERJ Open Res. 2024; 10(6).

PMID: 39588073 PMC: 11587053. DOI: 10.1183/23120541.00416-2024.


References
1.
Mastrovich J, Greenberger P . Psychogenic cough in adults: a report of two cases and review of the literature. Allergy Asthma Proc. 2002; 23(1):27-33. View

2.
Ing A, Breslin A . The patient with chronic cough. Med J Aust. 1997; 166(9):491-6. View

3.
Andrews G, Craig A . Prediction of outcome after treatment for stuttering. Br J Psychiatry. 1988; 153:236-40. DOI: 10.1192/bjp.153.2.236. View

4.
LAWLER W . An office approach to the diagnosis of chronic cough. Am Fam Physician. 1998; 58(9):2015-22. View

5.
Haque R, Usmani O, Barnes P . Chronic idiopathic cough: a discrete clinical entity?. Chest. 2005; 127(5):1710-3. DOI: 10.1378/chest.127.5.1710. View